Table 4.
6-month treatment | 12-month treatment | |||||
---|---|---|---|---|---|---|
1-5 visits | 6+ visits | 6+ vs 1-5 | 1-10 visits | 11+ visits | 11+ vs 1-10 | |
All-cause utilization (visits per month) | ||||||
Outpatient | 0.458*** | 0.640*** | 0.134* | 0.312*** | 0.578*** | 0.186* |
[0.423,0.494] | [0.603,0.676] | [0.006,0.263] | [0.269,0.354] | [0.536,0.619] | [0.035,0.337] | |
<0.001 | <0.001 | 0.040 | <0.001 | <0.001 | 0.016 | |
Inpatient | 0.003 | 0.002 | −0.004 | 0.003 | −0.001 | −0.002 |
[−0.000,0.006] | [−0.001,0.005] | [−0.015,0.007] | [−0.001,0.006] | [−0.004,0.003] | [−0.015,0.010] | |
0.096 | 0.312 | 0.519 | 0.166 | 0.647 | 0.710 | |
ED | −0.004* | −0.010*** | −0.005 | 0.000 | −0.001 | 0.000 |
[−0.008,−0.000] | [−0.014,−0.007] | [−0.016,0.006] | [−0.006,0.005] | [−0.005,0.003] | [−0.015,0.015] | |
0.033 | <0.001 | 0.365 | 0.881 | 0.689 | 0.966 | |
Any inpatient admissions or ED visits related to | ||||||
CHD | −0.004 | 0.010* | 0.019 | 0.010* | 0.005 | −0.002 |
[−0.013,0.005] | [0.000,0.019] | [−0.014,0.052] | [0.001,0.020] | [−0.005,0.014] | [−0.036,0.031] | |
0.406 | 0.044 | 0.249 | 0.037 | 0.333 | 0.899 | |
Stroke | −0.001 | 0.004 | 0.007 | −0.006** | 0.001 | 0.007 |
[−0.005,0.003] | [−0.000,0.009] | [−0.009,0.023] | [−0.009,−0.002] | [−0.003,0.005] | [−0.006,0.020] | |
0.740 | 0.059 | 0.371 | 0.002 | 0.587 | 0.295 | |
MACE | −0.003 | 0.002 | 0.013 | 0.007 | 0.001 | −0.002 |
[−0.013,0.006] | [−0.008,0.011] | [−0.021,0.047] | [−0.003,0.017] | [−0.009,0.010] | [−0.035,0.032] | |
0.480 | 0.706 | 0.443 | 0.201 | 0.916 | 0.923 | |
N treatment | 660 | 687 | 679 | 510 | 553 | 551 |
N control | 17,636 | 17,505 | 660 | 13,958 | 13,906 | 506 |
N total | 18,296 | 18,192 | 1,339 | 14,468 | 14,459 | 1,057 |
Notes: NFFCCM: non-face-to-face chronic care management. ED: emergency department. CHD: coronary heart disease. MACE: major adversed cardiovascular disease. For each outcome, the coefficient is listed and followed with its 95% confidence interval and p value. * p< 0.05, ** p< 0.01, *** p< 0.001.